New compounds based on a benzimidazole nucleus : synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines

  • Senem Akkoc
  • , Veysel Kayser
  • , İlhan Özer İlhan
  • , David E. Hibbs
  • , Yetkin Gok
  • , Peter A. Williams
  • , Bryson Hawkins
  • , Felcia Lai

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Abstract

Benzimidazolium salts and their Pyridine Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI) palladium N-heterocyclic carbene (Pd-NHC) based complexes have been synthesized and their structures characterized with a number of different instrumental techniques including NMR (H-1 and C-13), IR, EI-MS (for 2), X-ray (for 1, 2 and 4) and elemental analysis. The cytotoxicity of all the compounds was tested using the human embryonic kidney (HEK-293T), human breast epithelial adenocarcinoma (MDA-MB-231), and human colon epithelial colorectal adenocarcinoma (DLD-1) cell lines. The benzimidazolium salts (2-5) had more cytotoxic activity against cancerous cells compared with the metal complexes (6-9), which curiously exhibited no activity against any of the cell lines. Based on the IC50 values, compound 5 displayed the highest in vitro anticancer activity among compounds 2-9.
Original languageEnglish
Pages (from-to)98-107
Number of pages10
JournalJournal of Organometallic Chemistry
Volume839
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'New compounds based on a benzimidazole nucleus : synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines'. Together they form a unique fingerprint.

Cite this